The Readout: Speaking of Drug Prices
From the post:
How? Washington University law professor Rachel Sachs and Department of Veterans Affairs economist Austin Frakt suggest tying drug prices to cost-effectiveness. They'd also like society to pay more for preventive treatments and cures and less for lifelong treatments for chronic disease, in a bid to goad the industry to focus on developing treatments with more public benefit.
Read the full post herefda health law policy pharmaceuticals public health regulation